Delivery Order SPE2DB22D3501-SPE2DB25FVN18
Award Date 5/2/25
Potential Completion Date 5/23/25
Potential Value $4.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $16,462.32 to AmerisourceBergen Drug Corp for Testopel 75 mg pellets (100 count) on May 30, 2025, with an ultimate completion date of June 23, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania. Testopel is a testosterone replacement therapy product used in hormone treatment applications,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Testopel 75 mg pellets (100-count units) with a ceiling value of $4,115.58 and a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of October 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for Testopel 75 mg pellets valued at $10,289.00. This delivery order, issued on August 25, 2025, represents a firm fixed price contract with performance expected to conclude by September 16, 2025. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's established capability to...
- AmerisourceBergen Drug Corp received a delivery order award valued at $4,115.58 from the Defense Logistics Agency Medical Supply Chain on July 17, 2025, for the supply of Testopel 75 mg pellets (100-count units). The contract is a firm fixed-price delivery order with an ultimate completion date of August 7, 2025, and represents a non-competitive award executed under an existing contract vehicle. The work will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $4,000 to Amerisourcebergen Drug Corporation for the supply of 100 units of Testopel 75 mg pellets. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of three weeks concluding in early September. As a major supplier of pharmaceuticals to the Department of Defense, this order for testosterone replacement therapy supports DLA's provision of medical...
- The Defense Logistics Agency awarded a $3,978.08 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100 units of Testopel 75 mg pellets. Amerisourcebergen Drug Corporation will deliver the pellets to a location in Conshohocken, Pennsylvania under the terms of the order. As the prime contractor, Amerisourcebergen Drug Corporation is a division of Amerisourcebergen Corporation. The delivery order was issued on August 15, 2023 and has a period of performance...
- This is a $3,978.09 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,289,653 units of TESTOPEL 75 MG PELLETS 100S. The award is not associated with a set-aside program. Amerisourcebergen, through its Corporate Office division, provides a wide range of pharmaceutical and medical products to various government agencies, including the military, under multiple indefinite...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,115.58 firm-fixed-price contract is for the delivery of TESTOPEL 75 MG PELLETS 100S, a medical product, with a performance period through May 28, 2025. The contract is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract...
- This is a $4,115.58 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TESTOPEL 75 MG PELLETS 100S, a pharmaceutical product, with a period of performance through July 1, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of TESTOPEL 75 MG PELLETS 100S. The contract has a firm fixed price ceiling value of $11,934.27 and an ultimate completion date of August 2, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999.00 through...